Key points are not available for this paper at this time.
Creating clinical practice guidelines can be a long and expensive process, and guideline writers are always in search of funding. Enter the pharmaceutical industry. Of course, whenever drug companies foot the bill for any type of medical research, the question invariably arises: Will the money bias
Roger Collier (Mon,) studied this question.